Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026
Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle…
ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective…
Levicept Appoints Darlene Deptula-Hicks as CFO
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late…
BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement
NETANYA, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American:…
LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD
-- New Corporate Identity Reflects Strategic Transition into AI Energy Infrastructure Equipment…
Neuronetics to Participate in a Panel Discussion at B. Riley Securities’ Mind, Muscle & Vision Summit on July 16, 2026
July 06, 2026 08:30 ET | Source: Neuronetics MALVERN, Pa., July 06,…
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
WEST PALM BEACH, FL, July 06, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies…
Cannabix Technologies Announces Detection of Cocaine and Benzoylecgonine in Human Breath
VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc.…
Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor “What This Means” Segment
Access the segment here HOUSTON, July 06, 2026 (GLOBE NEWSWIRE) -- Moleculin…
